Acuerdo Marco para el suministro de medicamentos exclusivos para el Hospital Universitario Marqués de Valdecilla.
TED · 662282-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded—
WinnerGILEAD SCIENCES, S.L. | NOVARTIS FARMACEUTICA, S.A. | BRISTOL MYERS SQUIBB, S.A.U | JANSSEN CILAG, S.A. | VERTEX PHARMACEUTICALS SPAIN, S.L.
Who already wins at this buyer
Firms with recorded awards from Servicio Cántabro de Salud in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| LABORATORIOS VIIV HEALTHCARE S.L. | 2 | — | 2026-08-04 |
| SIEMENS HEALTHCARE S.L.U. | 1 | €2,000,000 | 2026-08-20 |
| SIEMENS HEALTHCARE, S.L.U. | 1 | €710,000 | 2026-08-19 |
| Carl Zeiss Meditec Iberia S.A.U | 1 | €320,000 | 2026-06-01 |
| EMBECTA MEDICAL SPAIN, S.L. | 1 | €234,000 | 2026-08-05 |
Full buyer profile: what Servicio Cántabro de Salud buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Acuerdo Marco para el suministro de medicamentos exclusivos para el Hospital Universitario Marqués de Valdecilla.
Similar tenders
Closest by meaning — across languages, via embeddings.